State of Wisconsin Investment Board’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-24,940
Closed -$33.7K 2395
2025
Q1
$33.7K Sell
24,940
-22,927
-48% -$139K ﹤0.01% 2216
2024
Q4
$630K Buy
47,867
+13,460
+39% +$184K ﹤0.01% 1705
2024
Q3
$386K Sell
34,407
-19,925
-37% -$249K ﹤0.01% 1977
2024
Q2
$584K Buy
54,332
+27,471
+102% +$354K ﹤0.01% 1748
2024
Q1
$400K Sell
26,861
-3,514
-12% -$58K ﹤0.01% 1862
2023
Q4
$550K Sell
30,375
-922
-3% -$14K ﹤0.01% 1681
2023
Q3
$543K Sell
31,297
-7,336
-19% -$127K ﹤0.01% 1713
2023
Q2
$700K Buy
38,633
+4,898
+15% +$116K ﹤0.01% 1630
2023
Q1
$897K Sell
33,735
-2,919
-8% -$83.1K ﹤0.01% 1520
2022
Q4
$709K Buy
+36,654
New +$766K ﹤0.01% 1722
2022
Q3
Sell
-78,200
Closed -$626K 2762
2022
Q2
$626K Buy
78,200
+34,300
+78% +$220K ﹤0.01% 1960
2022
Q1
$308K Buy
43,900
+29,200
+199% +$298K ﹤0.01% 2087
2021
Q4
$198K Hold
14,700
﹤0.01% 2093
2021
Q3
$248K Hold
14,700
﹤0.01% 2034
2021
Q2
$428K Hold
14,700
﹤0.01% 1722
2021
Q1
$578K Hold
14,700
﹤0.01% 1552
2020
Q4
$334K Buy
+14,700
New +$369K ﹤0.01% 1691

Other funds holding PLRX

State of Wisconsin Investment Board's PLRX Position: Q2 2025 in Review

State of Wisconsin Investment Board sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 24,940 shares — an estimated $33.7K sold.

State of Wisconsin Investment Board first reported a position in PLRX in Q4 2020 and held it in 17 quarters. The position peaked at $897K in Q1 2023. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

  • State of Wisconsin Investment Board reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 24,940 Pliant Therapeutics shares in Q2 2025, an estimated $33.7K.
  • State of Wisconsin Investment Board first reported a position in Pliant Therapeutics in Q4 2020 and held it in 17 quarters.
  • State of Wisconsin Investment Board's Pliant Therapeutics position peaked at $897K in Q1 2023.
  • 114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2025, filed 14 Aug 2025.